Global Precision Medicine Software Market 2020-2024

Global Precision Medicine Software Market 2020-2024.

The publisher has been monitoring the global precision medicine software market and it is poised to grow by USD 882.65 mn during 2020-2024, progressing at a CAGR of 11% during the forecast period. The report on the global precision medicine software market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by benefits of precision medicine. In addition, digitization of healthcare is anticipated to boost the growth of the global precision medicine software market as well.

Market Segmentation

The global precision medicine software market is segmented as below:

Delivery Mode:

On-premise
Cloud-based

Geographic Segmentation:

Asia
Europe
North America
ROW

Key Trends for global precision medicine software market growth

This study identifies digitization of healthcare as the prime reasons driving the global precision medicine software market growth during the next few years.

Prominent vendors in global precision medicine software market

The publisher a detailed analysis of around 25 vendors operating in the global precision medicine software market , including some of the vendors such as F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA and Syapse Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

Preface
Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis
Value Chain Analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2019
Market Outlook
Market size and forecast 2019-2024

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: MARKET SEGMENTATION BY DELIVERY MODE

Market segmentation by delivery mode
Comparison by delivery mode
On-premise - Market size and forecast 2019-2024
Cloud-based - Market size and forecast 2019-2024
Market opportunity by delivery mode

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 11: MARKET TRENDS

Rise in clinical trials in developing nations
Digitization of healthcare
Improvement in healthcare and IT infrastructure in emerging economies

PART 12: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

PART 13: VENDOR ANALYSIS

Vendors covered
Vendor classification
Market positioning of vendors
F. Hoffmann-La Roche Ltd.
Fabric Genomics, Inc.
Gene42 Inc.
Human Longevity, Inc.
International Business Machines Corp.
Koninklijke Philips NV
NantHealth Inc.
Roper Technologies Inc.
SOPHiA GENETICS SA
Syapse Inc.

PART 14: APPENDIX

Research methodology
List of abbreviations
Definition of market positioning of vendors

List of Exhibits

Exhibit 01: Global healthcare technology market
Exhibit 02: Segments of global healthcare technology market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key Offering
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Delivery mode - Market share 2019-2024 (%)
Exhibit 19: Comparison by delivery mode
Exhibit 20: On-premise - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: On-premise - Year-over-year growth 2020-2024 (%)
Exhibit 22: Cloud-based - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Cloud-based - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by delivery mode
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 45: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 46: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 47: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 48: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 49: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 50: Fabric Genomics Inc. - Vendor overview
Exhibit 51: Fabric Genomics Inc. - Product segments
Exhibit 52: Fabric Genomics Inc. - Organizational developments
Exhibit 53: Fabric Genomics Inc. - Key offerings
Exhibit 54: Gene42 Inc. - Vendor overview
Exhibit 55: Gene42 Inc. - Organizational developments
Exhibit 56: Gene42 Inc. - Key offerings
Exhibit 57: Human Longevity Inc. - Vendor overview
Exhibit 58: Human Longevity Inc. - Organizational developments
Exhibit 59: Human Longevity Inc. - Key offerings
Exhibit 60: International Business Machines Corp. - Vendor overview
Exhibit 61: International Business Machines Corp. - Business segments
Exhibit 62: International Business Machines Corp. - Organizational developments
Exhibit 63: International Business Machines Corp. - Geographic focus
Exhibit 64: International Business Machines Corp. - Segment focus
Exhibit 65: International Business Machines Corp. - Key offerings
Exhibit 66: Koninklijke Philips NV - Vendor overview
Exhibit 67: Koninklijke Philips NV - Business segments
Exhibit 68: Koninklijke Philips NV - Organizational developments
Exhibit 69: Koninklijke Philips NV - Geographic focus
Exhibit 70: Koninklijke Philips NV - Segment focus
Exhibit 71: Koninklijke Philips NV - Key offerings
Exhibit 72: NantHealth Inc. - Vendor overview
Exhibit 73: NantHealth Inc. - Product segments
Exhibit 74: NantHealth Inc. - Organizational developments
Exhibit 75: NantHealth Inc. - Segment focus
Exhibit 76: NantHealth Inc. - Key offerings
Exhibit 77: Roper Technologies Inc. - Vendor overview
Exhibit 78: Roper Technologies Inc. - Business segments
Exhibit 79: Roper Technologies Inc. - Organizational developments
Exhibit 80: Roper Technologies Inc. - Geographic focus
Exhibit 81: Roper Technologies Inc. - Segment focus
Exhibit 82: Roper Technologies Inc. - Key offerings
Exhibit 83: SOPHiA GENETICS SA - Vendor overview
Exhibit 84: SOPHiA GENETICS SA - Product segments
Exhibit 85: SOPHiA GENETICS SA - Organizational developments
Exhibit 86: SOPHiA GENETICS SA - Key offerings
Exhibit 87: Syapse Inc. - Vendor overview
Exhibit 88: Syapse Inc. - Product segments
Exhibit 89: Syapse Inc. - Organizational developments
Exhibit 90: Syapse Inc. - Key offerings
Exhibit 91: Validation techniques employed for market sizing
Exhibit 92: Definition of market positioning of vendors

Executive Summary

The publisher recognizes the following companies as the key players in the global precision medicine software market : F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA and Syapse Inc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the digitization of healthcare ."

According to the report, one of the major drivers for this market is the benefits of precision medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.